[Federal Register: April 23, 2004 (Volume 69, Number 79)]
[Notices]
[Page 22054-22055]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr23ap04-86]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-36-04]
Proposed Data Collections Submitted for Public Comment and
Recommendations
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 498-1210. Send written
comments to CDC, Desk Officer, Human Resources and Housing Branch, New
Executive Office Building, Room 10235, Washington, DC 20503 or by fax
to (202) 395-6974. Written comments should be received within 30 days
of this notice.
Proposed Project: Thyroid Disease in Persons Exposed to Radioactive
Fallout from Atomic Weapons Testing at the Nevada Test Site: Phase III
(OMB No. 0920-0504)--Extension--National Center for Environmental
Health (NCEH), Centers for Disease Control and Prevention (CDC).
In 1997, the National Cancer Institute (NCI) released a report
entitled, ``Estimated Exposures and Thyroid Doses Received by the
American People from I-131 in Fallout Following Nevada Nuclear Bomb
Test.'' This report provided county-level estimates of the potential
radiation doses to the thyroid gland of American citizens resulting
from atmospheric nuclear weapons testing at the Nevada Test Site (NTS)
in the 1950s and 1960s. The Institute of Medicine (IOM) conducted a
formal peer review of the report at the request of the Department of
Health and Human Services. In the review, IOM noted that the public
might desire an assessment of the potential health impact of nuclear
weapons testing on American populations. The IOM also suggested that
further studies of the Utah residents who have participated in previous
studies of radiation exposure and thyroid disease might provide this
information.
CDC, National Center for Environmental Health proposes to conduct a
study of the relation between exposure to radioactive fallout from
atomic weapons testing and the occurrence of thyroid disease on an
extension of a cohort study previously conducted by the University of
Utah, Salt Lake City, Utah. This study is designed as a follow-up to a
retrospective cohort study begun in 1965. This is the third examination
(hence Phase III) of a cohort of individuals comprised of persons who
were children living in Washington County, Utah, and Lincoln County,
Nevada, in 1965 (Phase I) and who were presumably exposed to fallout
from above-ground nuclear weapons testing at the Nevada Test Site in
the 1950s. The cohort also includes a control group comprised of
persons who were children living in Graham County, Arizona, in 1966 and
presumably unexposed to fallout.
The study headquarters will be at the University of Utah in Salt
Lake City, Utah. The field teams will spend the majority of their time
in the urban areas nearest the original counties if the same pattern of
migration holds same as that was found in Phase II. These urban areas
include: St. George, Utah; the Wasatch Front in Utah; Las Vegas,
Nevada; Phoenix/Tucson, Arizona; and Denver, Colorado. In addition,
some time will be spent in California as a number of subjects were
relocated there during the time of Phase II. The purpose of Phase III
is three-fold. First, the participants in Phase II will be re-examined
for occurrence of thyroid neoplasia and other diseases since 1986, and
residents of the three counties who moved before they could be included
in the original cohort will be located and examined. Second, disease
incidence will be analyzed in addition to period prevalence as used in
the Phase II analysis, and incidence analysis will allow for greater
power to detect increased risk of disease in the exposed population
through the use of person-time. Third, disease specific mortality rates
for Washington County, Utah, and a control county, Cache County, Utah,
will be compared to people who lived in these two counties during the
time of above-ground testing. This comparison will determine if the
risk of mortality in Washington County (the exposed group) is
significantly greater than Cache County (the control group). CDC, NCEH
is requesting a three-year clearance. The estimated annualized burden
is 3,368 hours.
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Respondents respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Telephone Location Script....................................... 1,200 1 5/60
Telephone Location Script (return letter)....................... 67 1 5/60
Refusal Telephone Script........................................ 50 1 5/60
Recruitment Next of Kin Telephone Script........................ 75 1 5/60
Recruitment & Appointment Script................................ 960 1 5/60
Broken Appointment Telephone Script............................. 40 1 5/60
Exposure Questionnaire.......................................... 167 1 90/60
[[Page 22055]]
Questionnaire Preparation Booklet............................... 960 1 30/60
Group Member Information........................................ 960 1 5/60
Consent Forms................................................... 960 1 5/60
Interview Booklet............................................... 167 1 30/60
Medical History Questionnaire (male)............................ 520 1 2
Medical History Questionnaire (female).......................... 520 1 2
Medical Records Release Telephone Script........................ 40 1 5/60
Thyroid Exam.................................................... 520 1 1
Travel Form..................................................... 80 1 20/60
Residence History............................................... 167 1 5/60
Refusal Questionnaire........................................... 8 1 5/60
----------------------------------------------------------------------------------------------------------------
Dated: April 16, 2004.
Bill J. Atkinson,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 04-9237 Filed 4-22-04; 8:45 am]
BILLING CODE 4163-18-P